Sana Biotechnology (SANA) Invested Capital (2020 - 2026)

Sana Biotechnology's Invested Capital history runs 7 years deep, the most recent figure standing at $172.8 million for Q1 2026.

• In Q1 2026, Invested Capital fell 17.35% year-over-year to $172.8 million; the TTM figure through Mar 2026 stood at $172.8 million (down 17.35% YoY), while the FY2025 annual figure was $201.1 million, down 19.73% from the prior year.
• Invested Capital came in at $172.8 million for Q1 2026 at Sana Biotechnology, down from $201.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $752.6 million in Q1 2022 to a low of $122.6 million in Q2 2025.
• A 5-year average of $372.6 million and a median of $339.6 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital decreased 12.87% in 2024 and tumbled 63.92% in 2025, its largest moves.
• Sana Biotechnology's Invested Capital stood at $554.7 million in 2022, then slumped by 48.17% to $287.5 million in 2023, then fell by 12.87% to $250.5 million in 2024, then dropped by 19.73% to $201.1 million in 2025, then fell by 14.07% to $172.8 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $172.8 million, $201.1 million, and $195.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison